About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Viability of shRNA Therapy for Huntington's Disease

by Aishwarya Radhakrishnan on December 2, 2017 at 11:51 PM
Font : A-A+

Viability of shRNA Therapy for Huntington's Disease

It was found that after many years of development, RNAi therapeutics are nearing the clinic. There are several variants on RNAi therapeutics, such as antisense oligonucleotides (ASOs), short-hairpin RNA (shRNA), small interfering RNA (siRNA), et cetera.

The researchers' paper aimed to answer the question of why RNAi therapeutics for nucleotide repeat disorders (specifically Huntington's, a devastating genetic neurodegenerative disease), have lost favor in recent years.

Advertisement


"We compared various RNAi-based therapeutic modalities available for the treatment of Huntington's Disease and offered mechanistic proposals on how to break through current barriers to clinical development. One key problem has proven to be modulating the expression level of shRNA constructs, which would otherwise be the clear frontrunner among ASOs, siRNAs, and other methods due to duration of expression, dramatically reduced off-target effects, and ease of delivery by adeno-associated viruses that are already approved by the EMA and FDA. We also put forward novel methods of modulating construct expression and avoiding off-target effects" said Franco Cortese, co-author of the paper and Deputy Director of the Biogerontology Research Foundation.

The researchers analyzed available data on the levels of off-target effects associated with siRNA vs shRNA, surveyed emerging strategies to reduce off-target effects in shRNA therapies (such as tough decoy RNAs, or TuDs), and proposed novel methods of controlling shRNA expression, in particular through the use of negative feedback-driven oscillating promoters.
Advertisement

"We proposed two novel feedback mechanisms that 1) activate construct expression stoichiometrically with mutant Huntingtin expression, or 2) only during aggregate-induced autophagy and lysosomal biogenesis. That way, the problem of excessive construct expression may be mitigated. These ideas were inspired by feedback systems used in synthetic biology, and in 'nonsynthetic,' naturally occurring biological systems" said Sebastian Aguiar, lead author of the paper.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Reiki and Pranic Healing 

Recommended Reading
Data Network Developed for Scientists Researching on Huntington's Disease
While Huntington's Disease is caused by a single gene mutation, the manifestation of the disease at ...
Therapy for Parkinson's may prove effective for Alzheimer's and Huntington's Disease
Neurodegenerative diseases are progressive, debilitating and incurable. Alzheimer's destroys ......
What Mechanism Drives Cognitive Symptoms in Huntington's Disease?
There is very little information about how the mutant Huntingtin gene contributes to cognitive and ....
Messenger in Huntington's Disease Pathogenesis
New information on the molecular mechanisms that cause Huntington's disease has been published by a ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use